About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [332 citations: 101–200 of 315 articles]

Articles published in Prostate Cancer have been cited 332 times. The following is a list of the 315 articles that have cited the articles published in Prostate Cancer.

  • Yoshiro Sakamoto, Kaori Fukaya, Masaki Haraoka, Kosuke Kitamura, Yoichiro Toyonaga, Michio Tanaka, and Shigeo Horie, “Analysis of prostate cancer localization toward improved diagnostic accuracy of transperineal prostate biopsy,” Prostate International, vol. 2, no. 3, pp. 114–120, 2014. View at Publisher · View at Google Scholar
  • Inna Armandari, Agus Rizal Hamid, Gerald Verhaegh, and Jack Schalken, “Intratumoral steroidogenesis in castration-resistant prostate cancer: a target for therapy,” Prostate International, vol. 2, no. 3, pp. 105–113, 2014. View at Publisher · View at Google Scholar
  • Suzanne M. Miller, Pagona Roussi, John Scarpato, Kuang-Yi Wen, Fang Zhu, and Gem Roy, “Randomized trial of print messaging: the role of the partner and monitoring style in promoting provider discussions about prostate cancer screening among African American men,” Psycho-Oncology, vol. 23, no. 4, pp. 404–411, 2014. View at Publisher · View at Google Scholar
  • Andrew M. McDonald, Christopher B. Baker, Richard A. Popple, Kiran Shekar, Eddy S. Yang, Rojymon Jacob, Rex Cardan, Robert Y. Kim, and John B. Fiveash, “Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy,” Radiation Oncology, vol. 9, 2014. View at Publisher · View at Google Scholar
  • Stine Elleberg Petersen, Lise Bentzen, Katrine J. Emmertsen, Soren Laurberg, Lilli Lundby, and Morten Hoyer, “Development and validation of a scoring system for late anorectal side-effects in patients treated with radiotherapy for prostate cancer,” Radiotherapy and Oncology, vol. 111, no. 1, pp. 94–99, 2014. View at Publisher · View at Google Scholar
  • Filippo Ammazzalorso, Sebastian Graef, Uli Weber, Andrea Wittig, Rita Engenhart-Cabillic, and Urszula Jelen, “Dosimetric consequences of intrafraction prostate motion in scanned ion beam radiotherapy,” Radiotherapy and Oncology, 2014. View at Publisher · View at Google Scholar
  • Traian Vasile Constantin, Victor Lucian Madan, Maria-Magdalena Constantin, Silviu-Horia Morariu, and Bogdan Braticevici, “The Role of Prostate-Specific Antigen in Prostate Cancer Screening,” Revista Romana de Medicina de Laborator, vol. 22, no. 2, pp. 275–281, 2014. View at Publisher · View at Google Scholar
  • Oleg A. Bobrenkov, Jaeyeon Lee, and Wooram Park, “A new geometry-based plan for inserting flexible needles to reach multiple targets,” Robotica, vol. 32, pp. 985–1004, 2014. View at Publisher · View at Google Scholar
  • Kanerva Lahdensuo, Tuomas Mirtti, Anssi Petas, and Antti Rannikko, “Performance of transrectal prostate biopsies in detecting tumours and implications for focal therapy,” Scandinavian Journal of Urology, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Zhu Mei, HuiKe Jiao, Wei Wang, Jie Li, GuoQiang Chen, and Ying Xu, “Polycomb chromobox 4 enhances migration and pulmonary metastasis of hepatocellular carcinoma cell line MHCC97L,” Science China Life Sciences, 2014. View at Publisher · View at Google Scholar
  • Chunxia Gao, Emer Bourke, Martin Scobie, Melina Arcos Famme, Tobias Koolmeister, Thomas Helleday, Leif A. Eriksson, Noel F. Lowndes, and James A. L. Brown, “Rational design and validation of a Tip60 histone acetyltransferase inhibitor,” Scientific Reports, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Zeta Tak For Yu, Koh Meng Aw Yong, and Jianping Fu, “Microfluidic Blood Cell Sorting: Now and Beyond,” Small, 2014. View at Publisher · View at Google Scholar
  • Edward Vitkin, Amir Ben-Dor, Michael Shmoish, Michaela F. Hartmann, Zohar Yakhini, Stefan A. Wudy, and Ze’ev Hochberg, “Peer Group Normalization and Urine to Blood Context in Steroid Metabolomics: the Case of CAH and Obesity,” Steroids, 2014. View at Publisher · View at Google Scholar
  • Ann W. Hsing, Edward Yeboah, Richard Biritwum, Yao Tettey, Angelo M. De Marzo, Andrew Adjei, George J. Netto, Kai Yu, Yan Li, Anand P. Chokkalingam, Lisa W. Chu, David Chia, Alan Partin, Ian M. Thompson, Sabah M. Quraishi, Shelley Niwa, Robert Tarone, and Robert N. Hoover, “High Prevalence of Screen Detected Prostate Cancer in West Africans: Implications for Racial Disparity of Prostate Cancer,” The Journal of Urology, 2014. View at Publisher · View at Google Scholar
  • Berat Cem Özgür, Ersin Köseoğlu, Ali İhsan Arık, Haşmet Sarıcı, Övünç Bilgin, Cem Nedim Yücetürk, Elif Özer, Eşref Oğuz Güven, Onur Telli, Ali Atan, and Muzaffer Eroğlu, “Synchronous bladder and prostate cancers in the specimens of radical cystoprostatectomy: A multicenter retrospective analysis,” The Kaohsiung Journal of Medical Sciences, 2014. View at Publisher · View at Google Scholar
  • Elizabeth A. Tindall, L. Richard Monare, Desiree C. Petersen, Smit van Zyl, Rae-Anne Hardie, Alpheus M. Segone, Philip A. Venter, M.S. Riana Bornman, and Vanessa M. Hayes, “Clinical presentation of prostate cancer in Black South Africans,” The Prostate, 2014. View at Publisher · View at Google Scholar
  • Masaki Shiota, Akira Yokomizo, Ario Takeuchi, Momoe Itsumi, Kenjiro Imada, Eiji Kashiwagi, Junichi Inokuchi, Katsunori Tatsugami, Takeshi Uchiumi, and Seiji Naito, “Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer,” The Prostate, 2014. View at Publisher · View at Google Scholar
  • Nadia Ashour, Javier C. Angulo, Guillermo Andrés, Raúl Alelú, Ana González-Corpas, María V. Toledo, José M. Rodríguez-Barbero, Jose I. López, Manuel Sánchez-Chapado, and Santiago Ropero, “A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis,” The Prostate, 2014. View at Publisher · View at Google Scholar
  • Angela Calastretti, Giuliana Gatti, Carolina Quaresmini, and Annamaria Bevilacqua, “Down-modulation of Bcl-2 sensitizes PTEN-mutated prostate cancer cells to starvation and taxanes,” The Prostate, 2014. View at Publisher · View at Google Scholar
  • A. Brett Hauber, Jorge Arellano, Yi Qian, Juan Marcos González, Joshua D. Posner, Ateesha F. Mohamed, Francesca Gatta, Bertrand Tombal, and Jean-Jacques Body, “Patient preferences for treatments to delay bone metastases,” The Prostate, 2014. View at Publisher · View at Google Scholar
  • Kenneth C. Valkenburg, Xiuping Yu, Angelo M. De Marzo, Tyler J. Spiering, Robert J. Matusik, and Bart O. Williams, “Activation of Wnt/β-catenin signaling in a subpopulation of murine prostate luminal epithelial cells induces high grade prostate intraepithelial neoplasia,” The Prostate, 2014. View at Publisher · View at Google Scholar
  • Cheryl D. Cropp, Christiane M. Robbins, Xin Sheng, Anselm J.M. Hennis, John D. Carpten, Lyndon Waterman, Ronald Worrell, Tae-Hwi Schwantes-An, Jeffrey M. Trent, Christopher A. Haiman, M. Cristina Leske, Suh-Yuh Wu, Joan E. Bailey-Wilson, and Barbara Nemesure, “8q24 risk alleles and prostate cancer in African-Barbadian men,” The Prostate, 2014. View at Publisher · View at Google Scholar
  • Petra Hudler, Nina Kocevar, and Radovan Komel, “Proteomic Approaches in Biomarker Discovery: New Perspectives in Cancer Diagnostics,” The Scientific World Journal, vol. 2014, pp. 1–18, 2014. View at Publisher · View at Google Scholar
  • Nihar K. Patel, Antoine Finianos, Kristen D. Whitaker, and Jeanny B. Aragon-Ching, “Advanced prostate cancer - patient survival and potential impact of enzalutamide and other emerging therapies,” Therapeutics and Clinical Risk Management, vol. 10, pp. 651–664, 2014. View at Publisher · View at Google Scholar
  • Ruiqin Wu, Yaxiong Cui, Xiaoyan Yuan, Haitao Yuan, Yimei Wang, Jun He, Jun Zhao, and Shuangqing Peng, “SUMO-specific protease 1 modulates cadmium-augmented transcriptional activity of androgen receptor (AR) by reversing AR SUMOylation,” Toxicology Letters, vol. 229, no. 2, pp. 405–413, 2014. View at Publisher · View at Google Scholar
  • Anna Supernat, Sylwia Łapińska-Szumczyk, Hanna Majewska, Jacek Gulczyński, Wojciech Biernat, Dariusz Wydra, and Anna J. Żaczek, “Tumor Heterogeneity at Protein Level as an Independent Prognostic Factor in Endometrial Cancer,” Translational Oncology, 2014. View at Publisher · View at Google Scholar
  • Erik H. Knelson, Jasmine C. Nee, and Gerard C. Blobe, “Heparan sulfate signaling in cancer,” Trends in Biochemical Sciences, 2014. View at Publisher · View at Google Scholar
  • Juliana Inês Santos, Ana Luísa Teixeira, Francisca Dias, Mónica Gomes, Augusto Nogueira, Joana Assis, and Rui Medeiros, “Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development,” Tumor Biology, 2014. View at Publisher · View at Google Scholar
  • Xiao-Feng He, Zhi-Zhong Liu, Jian-Jun Xie, Wei Wang, Ya-Ping Du, Yu Chen, and Wu Wei, “Association between the CYP3A4 and CYP3A5 polymorphisms and cancer risk: a meta-analysis and meta-regression,” Tumor Biology, 2014. View at Publisher · View at Google Scholar
  • Yuan Pei, Yue Xu, and Wenquan Niu, “Causal relevance of circulating adiponectin with cancer: a meta-analysis implementing Mendelian randomization,” Tumor Biology, 2014. View at Publisher · View at Google Scholar
  • Jacques Gilloteaux, James M. Jamison, Deborah Neal, and Jack L. Summers, “Synergistic Antitumor Cytotoxic Actions of Ascorbate and Menadione on Human Prostate (DU145) Cancer Cells In Vitro: Nucleus and Other Injuries Preceding Cell Death by Autoschizis,” Ultrastructural Pathology, vol. 38, no. 2, pp. 116–140, 2014. View at Publisher · View at Google Scholar
  • Jian Gang Pan, Chun Jiang, Runqi Luo, and Xing Zhou, “Association of Metabolic Syndrome and Benign Prostatic Hyperplasia in Chinese Patients of Different Age Decades,” Urologia Internationalis, vol. 93, no. 1, pp. 10–16, 2014. View at Publisher · View at Google Scholar
  • Monique J. Roobol, “International Perspectives on Screening,” Urologic Clinics of North America, vol. 41, no. 2, pp. 237–247, 2014. View at Publisher · View at Google Scholar
  • Akshay Sood, Wooju Jeong, James O. Peabody, Ashok K. Hemal, and Mani Menon, “Robot-Assisted Radical Prostatectomy,” Urologic Clinics of North America, 2014. View at Publisher · View at Google Scholar
  • Huan Ding, Ying Sun, Yu Hou, and Li Li, “Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy—Resistant prostate cancer cell line, PC3,” Urologic Oncology: Seminars and Original Investigations, 2014. View at Publisher · View at Google Scholar
  • Brandon A. Mahal, David R. Ziehr, Ayal A. Aizer, Andrew S. Hyatt, Jesse D. Sammon, Marianne Schmid, Toni K. Choueiri, Jim C. Hu, Christopher J. Sweeney, Clair J. Beard, Anthony V. D׳Amico, Neil E. Martin, Christopher Lathan, Simon P. Kim, Quoc-Dien Trinh, and Paul L. Nguyen, “Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer,” Urologic Oncology: Seminars and Original Investigations, 2014. View at Publisher · View at Google Scholar
  • David R. Ziehr, Brandon A. Mahal, Ayal A. Aizer, Andrew S. Hyatt, Clair J. Beard, Anthony V. D׳Amico, Toni K. Choueiri, Aymen Elfiky, Christopher S. Lathan, Neil E. Martin, Christopher J. Sweeney, Quoc-Dien Trinh, and Paul L. Nguyen, “Income inequality and treatment of African American men with high-risk prostate cancer,” Urologic Oncology: Seminars and Original Investigations, 2014. View at Publisher · View at Google Scholar
  • Dae-Seon Yoo, Seung Hyo Woo, Seok Cho, Seok Ho Kang, Sang Jin Kim, Sung Yul Park, Sang Hyub Lee, Seung Hyun Jeon, and Jinsung Park, “Practice Patterns of Urologists in Managing Korean Men Aged 40 Years or Younger With High Serum Prostate-specific Antigen Levels,” Urology, 2014. View at Publisher · View at Google Scholar
  • Jonathan L. Silberstein, Allison H. Feibus, Michael M. Maddox, Asim B. Abdel-Mageed, Krishnarao Moparty, Raju Thomas, and Oliver Sartor, “Active Surveillance of Prostate Cancer in African American Men,” Urology, 2014. View at Publisher · View at Google Scholar
  • Brandon A. Mahal, Michael P. O'Leary, and Paul L. Nguyen, “Hydrogel Spacing for Radiotherapy of Prostate Cancer: A Review of the Literature,” Urology Practice, 2014. View at Publisher · View at Google Scholar
  • Jakub Dobruch, Sebastian Piotrowicz, Michal Skrzypczyk, Tomasz Golabek, Piotr Chlosta, and Andrzej Borowka, “Clinical value of extended pelvic lymph node dissection in patients subjected to radical prostatectomy,” Videosurgery and Other Miniinvasive Techniques, vol. 9, no. 1, pp. 64–70, 2014. View at Publisher · View at Google Scholar
  • C. Wetterauer, M. Weibel, J. R. Gsponer, T. Vlajnic, T. Zellweger, S. Bütikofer, G. Müller, H. Püschel, A. Bachmann, T. C. Gasser, L. Bubendorf, and C. A. Rentsch, “Incidental prostate cancer prevalence at radical cystoprostatectomy—importance of the histopathological work-up,” Virchows Archiv, 2014. View at Publisher · View at Google Scholar
  • Nicolas Koutlidis, Celine Duperron, Mathilde Funes de la Vega, Eric Mourey, Frederic Michel, and Luc Cormier, “Capsular incision in normal prostatic tissue during robot-assisted radical prostatectomy: a new concept or a waste of time?,” World Journal of Urology, vol. 32, no. 5, pp. 1235–1240, 2014. View at Publisher · View at Google Scholar
  • Marianne Schmid, Qd Quoc-Dien Trinh, Markus Graefen, Margit Fisch, Felix K. Chun, and Jens Hansen, “The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: Which markers matter and how should they be used?,” World Journal of Urology, vol. 32, no. 4, pp. 871–880, 2014. View at Publisher · View at Google Scholar
  • Adam D. Toll, and Syed Z. Ali, “Urinary Cytomorphology and Clinical Correlates of Prostatic Small Cell Neuroendocrine Carcinoma,” Acta Cytologica, vol. 57, no. 5, pp. 495–500, 2013. View at Publisher · View at Google Scholar
  • Anna Pettersson, Ingela Turesson, Christina Persson, and Birgitta Johansson, “Assessing patients’ perceived bother from the gastrointestinal side effects of radiotherapy for localized prostate cancer: Initial questionnaire development and validation,” Acta Oncologica, pp. 1–10, 2013. View at Publisher · View at Google Scholar
  • Kevin Krughoff, Khadijah Eid, Jason Phillips, Diliana Stoimenova, Daniel Smith, Colin O’Donnell, E. David Crawford, and Al Barqawi, “The Accuracy of Prostate Cancer Localization Diagnosed on Transrectal Ultrasound-Guided Biopsy Compared to 3-Dimensional Transperineal Approach,” Advances in Urology, vol. 2013, pp. 1–5, 2013. View at Publisher · View at Google Scholar
  • H. S. Park, J. D. Schoenfeld, R. B. Mailhot, M. Shive, R. I. Hartman, R. Ogembo, and L. A. Mucci, “Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis,” Annals of Oncology, 2013. View at Publisher · View at Google Scholar
  • Tanya I. Stoyanova, and Andrew S. Goldstein, “Identification, characterization and targeting of Docetaxel-resistant prostate cancer cells,” Asian Journal Of Andrology, vol. 15, no. 1, pp. 83–84, 2013. View at Publisher · View at Google Scholar
  • Yun-Fei Li, Shao-Feng Zhang, Tao-Tao Zhang, Lei Li, Wei Gan, Hong-Tao Jia, Sheng Xie, Hui-Hua Ji, and Da-Lin He, “Intermittent tri-weekly docetaxel plus bicalutamide in patients with castration-resistant prostate cancer: a single-arm prospective study using a historical control for comparison,” Asian Journal of Andrology, 2013. View at Publisher · View at Google Scholar
  • Dong Il Kang, Jae Il Chung, Hong Koo Ha, Kweonsik Min, Jangho Yoon, Wansuk Kim, Won Ik Seo, Pil moon Kang, Soo Jin Jung, and Isaac Yi Kim, “Korean Prostate Cancer Patients Have Worse Disease Characteristics than their American Counterparts,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 11, pp. 6913–6917, 2013. View at Publisher · View at Google Scholar
  • Mathis Grossmann, Ada S. Cheung, and Jeffrey D. Zajac, “Androgens and prostate cancer; pathogenesis and deprivation therapy,” Best Practice & Research Clinical Endocrinology & Metabolism, 2013. View at Publisher · View at Google Scholar
  • Jean-Joseph Hoang, Silvère Baron, David H. Volle, Jean-Marc A. Lobaccaro, and Amalia Trousson, “Lipids, LXRs and prostate cancer: Are HDACs a new link?,” Biochemical Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Hai-Dong Yao, Qiong Wu, Zi-Wei Zhang, Shu Li, Xiao-Long Wang, Xin-Gen Lei, and Shi-Wen Xu, “Selenoprotein W serves as an antioxidant in chicken myoblasts,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1830, no. 4, pp. 3112–3120, 2013. View at Publisher · View at Google Scholar
  • Sophie E McGrath, Agnieszka Michael, Richard Morgan, and Hardev Pandha, “EN2: a novel prostate cancer biomarker,” Biomarkers in Medicine, vol. 7, no. 6, pp. 893–901, 2013. View at Publisher · View at Google Scholar
  • Awatef Ben Jemaa, Yosra Bouraoui, Sataa Sallami, Yassine Nouira, and Ridha Oueslati, “A Comparison of the Biological Features of Prostate Cancer with (PSA+, PSMA+) Profile according to RKIP,” BioMed Research International, vol. 2013, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  • M. L. Verschoor, R. Ungard, A. Harbottle, J. P. Jakupciak, R. L. Parr, and G. Singh, “Mitochondria and Cancer: Past, Present, and Future,” Biomed Research International, 2013. View at Publisher · View at Google Scholar
  • Martin Andreas Røder, Klaus Brasso, Ib Jarle Christensen, Jørgen Johansen, Niels Christian Langkilde, Helle Hvarness, Steen Carlsson, Henrik Jakobsen, Michael Borre, and Peter Iversen, “Survival after radical prostatectomy for clinically localised prostate cancer: a population-based study,” BJU International, 2013. View at Publisher · View at Google Scholar
  • Bao-Li Chang, Lucinda Hughes, David Y.T. Chen, Laura Gross, Karen Ruth, and Veda N. Giri, “Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer,” BJU International, 2013. View at Publisher · View at Google Scholar
  • H. Ballentine Carter, “American Urological Association (AUA) Guideline on prostate cancer detection: process and rationale,” BJU International, vol. 112, no. 5, pp. 543–547, 2013. View at Publisher · View at Google Scholar
  • Christian Barré, Matthieu Thoulouzan, Geneviève Aillet, and Jean-Michel Nguyen, “Assessing the extirpative quality of a radical prostatectomy technique: categorisation and mapping of technical errors,” BJU International, 2013. View at Publisher · View at Google Scholar
  • Philip A. Fontenot, and Ahmed M. Mansour, “Reporting positive surgical margins after radical prostatectomy: time for standardization,” BJU International, 2013. View at Publisher · View at Google Scholar
  • Elizabeth A. Tindall, M. S. Riana Bornman, Smit van Zyl, Alpheus M. Segone, L. Richard Monare, Philip A. Venter, and Vanessa M. Hayes, “Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South Africa,” Bmc Urology, vol. 13, 2013. View at Publisher · View at Google Scholar
  • Joshua B. Stevens, Steven D. Horne, Batoul Y. Abdallah, Christine J. Ye, and Henry H. Heng, “Chromosomal instability and transcriptome dynamics in cancer,” Cancer and Metastasis Reviews, 2013. View at Publisher · View at Google Scholar
  • Archana Mukhopadhyay, Kayann Tabanor, Rathnam Chaguturu, and Jane V Aldrich, “Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment,” Cancer Biology & Therapy, vol. 14, no. 10, 2013. View at Publisher · View at Google Scholar
  • Dana E. Rathkopf, Joel Picus, Arif Hussain, Susan Ellard, Kim Nguyen Chi, Thomas Nydam, Erin Allen-Freda, Kaushal Kishor Mishra, Maria Grazia Porro, Howard I. Scher, and George Wilding, “A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer,” Cancer Chemotherapy and Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Julie Ruterbusch, Cathryn H. Bock, Steve Lenk, Mehsati Herawi, Richard Everson, Craig N. Giroux, Ann G. Schwartz, Aliccia Bollig-Fischer, Isaac J. Powell, Greg Dyson, and Susan Land, “Genes Associated with Prostate Cancer Are Differentially Expressed in African American and European American Men,” Cancer Epidemiology Biomarkers & Prevention, vol. 22, no. 5, pp. 891–897, 2013. View at Publisher · View at Google Scholar
  • Michael R. Burgio, John P. A. Ioannidis, Brett M. Kaminski, Eric DeRycke, Scott Rogers, Muin J. Khoury, and Daniela Seminara, “Collaborative Cancer Epidemiology in the 21st Century: The Model of Cancer Consortia,” Cancer Epidemiology Biomarkers & Prevention, vol. 22, no. 12, pp. 2148–2160, 2013. View at Publisher · View at Google Scholar
  • Thippeswamy Gulappa, Ramadevi Subramani Reddy, Suman Suman, Alice M. Nyakeriga, and Chendil Damodaran, “Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells,” Cancer Letters, 2013. View at Publisher · View at Google Scholar
  • Brigitte N. Gomperts, Tonya C. Walser, Avrum Spira, and Steven M. Dubinett, “Enriching the Molecular Definition of the Airway "Field of Cancerization:" Establishing New Paradigms for the Patient at Risk for Lung Cancer,” Cancer Prevention Research, vol. 6, no. 1, pp. 4–7, 2013. View at Publisher · View at Google Scholar
  • Nicholas G. Zaorsky, Matthew T. Studenski, Adam P. Dicker, Leonard Gomella, and Robert B. Den, “Stereotactic body radiation therapy for prostate cancer: Is the technology ready to be the standard of care?,” Cancer Treatment Reviews, vol. 39, no. 3, pp. 212–218, 2013. View at Publisher · View at Google Scholar
  • S. Supiot, G. Créhange, I. Latorzeff, P. Pommier, A. Paumier, E. Rio, G. Delaroche, S. Guérif, C. Catton, J. Martin, and A. Lisbona, “Hypofractionnement à visée curative dans le cancer de la prostate,” Cancer/Radiothérapie, 2013. View at Publisher · View at Google Scholar
  • A. R. Verone, K. Duncan, A. Godoy, N. Yadav, A. Bakin, S. Koochekpour, J.-P. Jin, and H. V. Heemers, “Androgen-responsive Serum Response Factor target genes regulate prostate cancer cell migration,” Carcinogenesis, 2013. View at Publisher · View at Google Scholar
  • S Wang, J Huang, H Lyu, C-K Lee, J Tan, J Wang, and B Liu, “Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells,” Cell Death and Disease, vol. 4, no. 3, pp. e556, 2013. View at Publisher · View at Google Scholar
  • Zheng-Yuan Su, Tin Oo Khor, Limin Shu, Jong Hun Lee, Constance Lay-Lay Saw, Tien-Yuan Wu, Ying Huang, Nanjoo Suh, Chung S. Yang, Allan H. Conney, Qing Wu, and Ah-Ng Tony Kong, “ Epigenetic Reactivation of Nrf2 in Murine Prostate Cancer TRAMP C1 Cells by Natural Phytochemicals Z-Ligustilide and Radix Angelica Sinensis via Promoter CpG Demethylation ,” Chemical Research in Toxicology, vol. 26, no. 3, pp. 477–485, 2013. View at Publisher · View at Google Scholar
  • Kenneth C. Valkenburg, Matthew R. Steensma, Bart O. Williams, and Zhendong Zhong, “Skeletal metastasis: Treatments, mouse models, and the Wnt signaling,” Chinese Journal of Cancer, vol. 32, no. 7, pp. 380–396, 2013. View at Publisher · View at Google Scholar
  • S. Dijkstra, P.F.A. Mulders, and J.A. Schalken, “Clinical Use of Novel Urine and Blood Based Prostate Cancer Biomarkers: a review,” Clinical Biochemistry, 2013. View at Publisher · View at Google Scholar
  • Sucharitha Balasubramaniam, Clay E. S. Comstock, Adam Ertel, Kwang Won Jeong, Michael R. Stallcup, Sankar Addya, Peter A. McCue, William F. Ostrander, Michael A. Augello, and Karen E. Knudsen, “Aberrant BAF57 Signaling Facilitates Prometastatic Phenotypes,” Clinical Cancer Research, vol. 19, no. 10, pp. 2657–2667, 2013. View at Publisher · View at Google Scholar
  • Patrick Berkovic, Gert De Meerleer, Louke Delrue, Bieke Lambert, Valérie Fonteyne, Nicolaas Lumen, Karel Decaestecker, Geert Villeirs, Philippe Vuye, and Piet Ost, “Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy,” Clinical Genitourinary Cancer, vol. 11, no. 1, pp. 27–32, 2013. View at Publisher · View at Google Scholar
  • Matthew C. Ward, Rahul D. Tendulkar, Jay P. Ciezki, and Eric A. Klein, “Future Directions From Past Experience: A Century of Prostate Radiotherapy,” Clinical Genitourinary Cancer, 2013. View at Publisher · View at Google Scholar
  • S. Sridharan, A. Dal Pra, C. Catton, R.G. Bristow, and P. Warde, “Locally Advanced Prostate Cancer: Current Controversies and Optimisation Opportunities,” Clinical Oncology, 2013. View at Publisher · View at Google Scholar
  • L. Dickinson, H.U. Ahmed, A. Kirkham, C. Allen, A. Freeman, J. Barber, R. Hindley, T. Leslie, C. Ogden, R. Persad, M.H. Winkler, and M. Emberton, “A Multi-Centre Prospective Development Study Evaluating Focal Therapy using High Intensity Focused Ultrasound for Localised Prostate Cancer: The INDEX Study,” Contemporary Clinical Trials, 2013. View at Publisher · View at Google Scholar
  • Jeffry L. Dean, “The Role of Tumor Suppressor Dysregulation in Prostate Cancer Progression,” Current Drug Targets, vol. 14, no. 4, pp. 460–471, 2013. View at Publisher · View at Google Scholar
  • F. El-Gehani, K. Joseph, A. Dechaphunkul, M. Kamal, D. Pertschy, P. Venner, S. Ghosh, and S. North, “Genitourinary small-cell carcinoma: a single-institution experience,” Current Oncology, vol. 20, no. 5, pp. 258–264, 2013. View at Publisher · View at Google Scholar
  • Sausan Abouharb, and Paul G. Corn, “Optimal Therapy Sequencing in Metastatic Castration-Resistant Prostate Cancer,” Current Oncology Reports, vol. 15, no. 3, pp. 217–223, 2013. View at Publisher · View at Google Scholar
  • Sonia Liberati, Giorgio Santoni, Maria Beatrice Morelli, Massimo Nabissi, and Matteo Santoni, “Oncogenic and Anti-Oncogenic Effects of Transient Receptor Potential Channels,” Current Topics In Medicinal Chemistry, vol. 13, no. 3, pp. 344–366, 2013. View at Publisher · View at Google Scholar
  • Phillip J. Gray, and Jason A. Efstathiou, “Proton Beam Radiation Therapy for Prostate Cancer—Is the Hype (and the Cost) Justified?,” Current Urology Reports, 2013. View at Publisher · View at Google Scholar
  • Gonzalo Rodríguez-Berriguete, Beatriz Sánchez-Espiridión, José R. Cansino, Gabriel Olmedilla, Pilar Martínez-Onsurbe, Manuel Sánchez-Chapado, Ricardo Paniagua, Benito Fraile, and Mar Royuela, “Clinical significance of both tumor and stromal expression of components of the IL-1 and TNF-α signaling pathways in prostate cancer,” Cytokine, 2013. View at Publisher · View at Google Scholar
  • J. Hübner, “Update 2013 Komplementäre Onkologie,” Der Onkologe, 2013. View at Publisher · View at Google Scholar
  • B.J. Schmitz-Dräger, G. Lümmen, E. Bismarck, and C. Fischer, “Metabolisches Syndrom und Prostatakarzinom,” Der Urologe, 2013. View at Publisher · View at Google Scholar
  • Yan-bing Ding, Bin Deng, You-sheng Huang, Wei-ming Xiao, Jian Wu, Yan-qing Zhang, Yuan-zhi Wang, Da-cheng Wu, Guo-tao Lu, and Ke-yan Wu, “A High Level of Integrin α6 Expression in Human Intrahepatic Cholangiocarcinoma Cells Is Associated with a Migratory and Invasive Phenotype,” Digestive Diseases and Sciences, vol. 58, no. 6, pp. 1627–1635, 2013. View at Publisher · View at Google Scholar
  • Elizabeth M. Hechenbleikner, Jill C. Buckley, and Elizabeth C. Wick, “Acquired Rectourethral Fistulas in Adults,” Diseases of the Colon & Rectum, vol. 56, no. 3, pp. 374–383, 2013. View at Publisher · View at Google Scholar
  • Sébastien Fortin, Kevin Brasseur, Nathalie Morin, Éric Asselin, and Gervais Bérubé, “New platinum(II) complexes conjugate at position 7α of 17β-acetyl-testosterone as new combi-molecules against prostate cancer: Design, synthesis, structure-activity relationships and biological evaluation,” European Journal of Medicinal Chemistry, 2013. View at Publisher · View at Google Scholar
  • Amit Bahl, “Metastatic castration-resistant prostate cancer. Part 1: the challenges of the disease and its treatment,” European Journal of Oncology Nursing, vol. 17, pp. S1–S6, 2013. View at Publisher · View at Google Scholar
  • Andrew Close, Clare Robertson, Stephen Rushton, Mark Shirley, Luke Vale, Craig Ramsay, and Robert Pickard, “Comparative Cost-effectiveness of Robot-assisted and Standard Laparoscopic Prostatectomy as Alternatives to Open Radical Prostatectomy for Treatment of Men with Localised Prostate Cancer: A Health Technology Assessment from the Perspective of the UK National Health Service,” European Urology, 2013. View at Publisher · View at Google Scholar
  • Axel Heidenreich, Patrick J. Bastian, Joaquim Bellmunt, Michel Bolla, Steven Joniau, Theodor van der Kwast, Malcolm Mason, Vsevolod Matveev, Thomas Wiegel, F. Zattoni, and Nicolas Mottet, “EAU Guidelines on Prostate Cancer, Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2014,” European Urology, 2013. View at Publisher · View at Google Scholar
  • Zhijun Wang, Jeffery Fan, Mandy Liu, Steven Yeung, Andy Chang, Moses SS Chow, Doreen Pon, and Ying Huang, “Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application,” Expert Opinion on Investigational Drugs, pp. 1–14, 2013. View at Publisher · View at Google Scholar
  • Rahul R Deshmukh, Sara M Schmitt, Clara Hwang, and Qing Ping Dou, “Chemotherapeutic inhibitors in the treatment of prostate cancer,” Expert Opinion on Pharmacotherapy, pp. 1–12, 2013. View at Publisher · View at Google Scholar
  • Guillaume Ploussard, and Pierre Mongiat-Artus, “Triptorelin in the management of prostate cancer,” Future Oncology, vol. 9, no. 1, pp. 93–102, 2013. View at Publisher · View at Google Scholar
  • Michael Blaise Cook, Zhaoming Wang, Edward D. Yeboah, Yao Tettey, Richard B. Biritwum, Andrew A. Adjei, Evelyn Tay, Ann Truelove, Shelley Niwa, Charles C. Chung, Annand P. Chokkalingam, Lisa W. Chu, Meredith Yeager, Amy Hutchinson, Kai Yu, Kristin A. Rand, Christopher A. Haiman, Robert N. Hoover, Ann W. Hsing, and Stephen J. Chanock, “A genome-wide association study of prostate cancer in West African men,” Human Genetics, 2013. View at Publisher · View at Google Scholar